Drug Information

Drug General Information
Drug ID
D0X9YD
Former ID
DNC014435
Drug Name
ALLICIN
Drug Type
Small molecular drug
Indication Discovery agent Investigative [539548]
Formula
C6H10OS2
InChI
InChI=1S/C6H10OS2/c1-3-5-8-9(7)6-4-2/h3-4H,1-2,5-6H2
InChIKey
JDLKFOPOAOFWQN-UHFFFAOYSA-N
PubChem Compound ID
65036
PubChem Substance ID
9802, 529373, 640149, 7785165, 8189458, 12014323, 15194901, 26675631, 43121878, 50024491, 50388259, 53786775, 56314457, 57315252, 57391068, 93374769, 103451973, 104098517, 104332693, 117635742, 118048865, 119526511, 125352604, 126542419, 126689070, 128259149, 131318059, 132565109, 134351640, 135023252, 135651433, 136992433, 137231441, 139757665, 162183534, 162220031, 162546694, 163884506, 164806099, 174549347, 184548228, 198967867, 198967868, 221672641, 223673114, 223806358, 226395235, 241093322, 249810676
Target and Pathway
Target(s) Cysteine protease Target Info Inhibitor [531093]
References
Ref 539548(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2419).
Ref 531093Bioorg Med Chem Lett. 2010 Sep 15;20(18):5541-3. Epub 2010 Aug 6.Allicin and derivates are cysteine protease inhibitors with antiparasitic activity.